ACB vs. TLRY, CRON, THCX, GUD, CPH, OGI, FIRE, WEED, EPI, and ICC
Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Tilray Brands (TLRY), Cronos Group (CRON), Hydropothecary (THCX), Knight Therapeutics (GUD), Cipher Pharmaceuticals (CPH), Organigram (OGI), Supreme Cannabis (FIRE), Canopy Growth (WEED), ESSA Pharma (EPI), and ICC Labs (ICC). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Aurora Cannabis vs.
Aurora Cannabis (TSE:ACB) and Tilray Brands (TSE:TLRY) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.
Aurora Cannabis has a net margin of -22.55% compared to Tilray Brands' net margin of -30.02%. Tilray Brands' return on equity of -7.24% beat Aurora Cannabis' return on equity.
Aurora Cannabis has a beta of 2.71, suggesting that its stock price is 171% more volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 2.19, suggesting that its stock price is 119% more volatile than the S&P 500.
In the previous week, Tilray Brands had 2 more articles in the media than Aurora Cannabis. MarketBeat recorded 5 mentions for Tilray Brands and 3 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.34 beat Tilray Brands' score of 0.23 indicating that Aurora Cannabis is being referred to more favorably in the media.
Aurora Cannabis has higher earnings, but lower revenue than Tilray Brands. Aurora Cannabis is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.
Aurora Cannabis received 531 more outperform votes than Tilray Brands when rated by MarketBeat users. Likewise, 63.14% of users gave Aurora Cannabis an outperform vote while only 0.00% of users gave Tilray Brands an outperform vote.
13.4% of Aurora Cannabis shares are held by institutional investors. Comparatively, 11.2% of Tilray Brands shares are held by institutional investors. 0.7% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Aurora Cannabis presently has a consensus price target of C$7.48, suggesting a potential downside of 10.27%. Given Aurora Cannabis' stronger consensus rating and higher probable upside, analysts clearly believe Aurora Cannabis is more favorable than Tilray Brands.
Summary
Aurora Cannabis beats Tilray Brands on 11 of the 18 factors compared between the two stocks.
Get Aurora Cannabis News Delivered to You Automatically
Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aurora Cannabis Competitors List
Related Companies and Tools
This page (TSE:ACB) was last updated on 2/22/2025 by MarketBeat.com Staff
Free ACB Stock Alerts